In Phase 3 trials, it produced 22.7% average weight loss over 68 weeks , significantly more than semaglutide alone
Sources European Society of Cardiology, Obesity and Cardiovascular Disease: Clinical Consensus Statement European Medicines Agency, Wegovy (semaglutide) European Medicines Agency, Mounjaro (tirzepatide) European Medicines Agency, Ozempic (semaglutide) February 12, 2026 March 10, 2026 Start your weight loss journey with Yazen today Everything you need to do is to create an account and answer some questions about your health More articles Contraceptives and weight loss medications: How Wegovy and Mounjaro can affect the efficacy of birth control pills When treating with weight loss medications like Wegovy (semaglutide) and Mounjaro (tirzepatide), it is important to consider how the medications can affect fertility and the efficacy of contraceptives
[2] WikiDoc MAKES NO GUARANTEE OF VALIDITY
Thats why so many women choose to turn to plastic surgery
oral Semaglutide provides a more patient-friendly alternative, directly influencing its higher market share
Semaglutide 2.4 mg weekly showed average weight loss of about 15% of body weight in the STEP trials